Adams Sarah A, Leach Michelle Chan, Feudtner Chris, Miller Victoria A, Kenyon Chén Collin
The Children's Hospital of Philadelphia, PolicyLab and Center for Pediatric Clinical Effectiveness, Philadelphia, PA, United States.
Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, United States.
JMIR Res Protoc. 2017 Mar 27;6(3):e48. doi: 10.2196/resprot.6674.
The use of inhaled corticosteroid (ICS) medications has been shown to improve asthma control and reduce asthma-related morbidity and mortality. Two recent randomized trials demonstrated dramatic improvements in ICS adherence by monitoring adherence with electronic sensors and providing automated reminders to participants to take their ICS medications. Given their lower levels of adherence and higher levels of asthma-related emergency department (ED) visits, hospitalizations, and death, urban minority populations could potentially benefit greatly from these types of interventions.
The principal objective of this study will be to evaluate the feasibility, acceptability, and limited efficacy of a text message (short message service, SMS) reminder intervention to enhance ICS adherence in an urban minority population of children with asthma. We will also assess trajectories of ICS adherence in the 2 months following asthma hospitalization.
Participants will include 40 children aged 2-13 years, who are currently admitted to the Children's Hospital of Philadelphia (CHOP) for asthma, and their parent or legal guardian. Participants will be assigned to intervention and control arms using a 1:1 randomization scheme. The intervention arm will receive daily text message reminders for a 30-day intervention phase following hospitalization. This will be followed by a 30-day follow-up phase, in which all participants may choose whether or not to receive the text messages. Feasibility will be assessed by measuring (1) retention of the participants through the study phases and (2) perceived usefulness, acceptability, and preferences regarding the intervention components. Limited efficacy outcomes will include percent adherence to prescribed ICS regimen measured using Propeller Health sensors and change in parent-reported asthma control. We will perform an exploratory analysis to assess for discrete trajectories of adherence using group-based trajectory modeling (GBTM).
Study enrollment began in December 2015 and the intervention and follow-up phases are ongoing. Results of the data analysis are expected to be available by December 2016.
This study will add to the literature by providing foundational feasibility data on which elements of a mobile health text-message reminder intervention may need to be modified to suit the needs and constraints of high-risk urban minority populations.
Clinicaltrials.gov NCT02615743; https://www.clinicaltrials.gov/ct2/show/study/NCT02615743 (Archived with WebCite at http://www.webcitation.org/6ji59rAXN).
吸入性糖皮质激素(ICS)药物的使用已被证明可改善哮喘控制,并降低与哮喘相关的发病率和死亡率。最近的两项随机试验表明,通过使用电子传感器监测依从性并向参与者提供自动提醒以服用ICS药物,ICS依从性有显著改善。鉴于城市少数族裔人群的依从性较低,且与哮喘相关的急诊科就诊、住院和死亡水平较高,这类干预措施可能会使他们受益匪浅。
本研究的主要目的是评估短信(短消息服务,SMS)提醒干预措施在城市少数族裔哮喘儿童群体中提高ICS依从性的可行性、可接受性和有限疗效。我们还将评估哮喘住院后2个月内ICS依从性的轨迹。
参与者将包括40名年龄在2至13岁之间、目前因哮喘入住费城儿童医院(CHOP)的儿童及其父母或法定监护人。参与者将使用1:1随机化方案分配到干预组和对照组。干预组在住院后的30天干预阶段将收到每日短信提醒。随后是30天的随访阶段,在此阶段所有参与者可以选择是否接收短信。可行性将通过测量以下内容进行评估:(1)参与者在研究各阶段的留存率;(2)对干预组成部分的感知有用性、可接受性和偏好。有限疗效结果将包括使用Propeller Health传感器测量的规定ICS治疗方案的依从百分比以及家长报告的哮喘控制变化。我们将使用基于群体的轨迹模型(GBTM)进行探索性分析,以评估依从性的离散轨迹。
研究于2015年12月开始,干预和随访阶段正在进行中。数据分析结果预计在2016年12月可得。
本研究将通过提供基础可行性数据来丰富文献,这些数据涉及移动健康短信提醒干预措施的哪些要素可能需要修改,以适应高风险城市少数族裔人群的需求和限制。
Clinicaltrials.gov NCT02615743;https://www.clinicaltrials.gov/ct2/show/study/NCT02615743(存档于WebCite:http://www.webcitation.org/6ji59rAXN)